Neuronal adaptations, neuroendocrine and immune correlates of heroin self-administration

Brain, Behavior, and Immunity

Volumn 23, Issue 7, 2009, Pages 993-1002

  Weber, R J ^a,b   Gomez Flores, R ^b   Smith, J E ^c   Martin, T J ^c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

ACTH; Drug abuse; Glucocorticoid; Immunodeficiency; Neural plasticity; Opioid; Self administration; T lymphocyte

Indexed keywords

CONCANAVALIN A; CORTICOTROPIN; DIAMORPHINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GLUCOCORTICOID; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ARTICLE; BRAIN REGION; CD3+ T LYMPHOCYTE; CELL ACTIVITY; CONTROLLED STUDY; DRUG ABUSE; HEROIN DEPENDENCE; HYPOPLASIA; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION SENSITIVITY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MACROPHAGE FUNCTION; MALE; NATURAL KILLER CELL; NERVE CELL PLASTICITY; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; RECEPTOR DENSITY; SPLEEN; T LYMPHOCYTE; THYMUS;

ADRENOCORTICOTROPIC HORMONE; ANALYSIS OF VARIANCE; ANIMALS; AUTORADIOGRAPHY; BRAIN; CELL PROLIFERATION; CELLS, CULTURED; CORTICOSTERONE; CYTOTOXICITY, IMMUNOLOGIC; HEROIN; KILLER CELLS, NATURAL; MACROPHAGES; MALE; NITRIC OXIDE; RADIOIMMUNOASSAY; RATS; RATS, INBRED F344; RECEPTORS, OPIOID, MU; SELF ADMINISTRATION; SPLEEN; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349094437     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2009.05.057     Document Type: Article

References (94)

1. Ashwell J.D., Lu F.W., and Vacchio M.S. Glucocorticoids in T cell development and function. Annu. Rev. Immunol. 18 (2000) 309-345
2. Band L.C., Pert A., Williams W., de Costa B.R., Rice K.C., and Weber R.J. Central u-opioid receptors mediate suppression of natural killer activity in vivo. Prog. Neuroendocrinimmunol. 5 (1992) 95-101
3. Bayer B.M., Daussin S., Hernandez M., and Irvin L. Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacology 29 (1990) 369-374
4. Bayer B.M., Hernandez M., and Irvin L. Suppression of lymphocyte activity after acute morphine administration appears to be glucocorticoid independent. Alcohol Immunomodulat. AIDS 325 (1990) 273-282
5. Briggs J.H., McKerron C.G., Souhami R.L., Taylor D.J., and Andrews H. Severe systemic infections complicating "mainline" heroin addiction. Lancet 2 (1967) 1227-1231
6. Brown S.M., Stimmel B., Taub R.N., Kochwa S., and Rosenfield R.E. Immunologic dysfunction in heroin addicts. Arch. Intern. Med. 134 (1974) 1001-1006
7. Brown Z.W., Amit Z., and Weeks J.R. Simple flow-thru swivel for infusions into unrestrained animals. Pharmacol. Biochem. Behav. 5 (1976) 363-365
8. Bryant H.U., Bernton E.W., Kenner J.R., and Holaday J.W. Role of adrenal cortical activation in the immunosuppressive effects of chronic morphine treatment. Endocrinology 128 (1991) 3253-3258
9. Carr D.J., and Carpenter G.W. Morphine-induced suppression of cytotoxic T lymphocyte activity in alloimmunized mice is not mediated through a naltrindole-sensitive delta opioid receptor. Neuroimmunomodulation 2 (1995) 44-53
10. Carr D.J.J., and Serou M. Exogenous and endogenous opioids as biological response modifiers. Immunopharmacology 31 (1995) 59-71
11. Carr D.J.J., and Weber R.J. Psychoneuroimmunology, vol. 1. third ed. (2001), Academic Press, San Diego pp. 405-414
12. Carr D.J.J., Rogers T.J., and Weber R.J. The relevance of opioids and opioid receptors on immunocompetence and immune homeostasis. Proc. Soc. Exp. Biol. Med. 213 (1996) 248-257
13. Chao J., and Nestler E.J. Molecular neurobiology of drug addiction. Annu. Rev. Med. 55 (2004) 113-132
14. Contet C., Kieffer B.L., and Befort K. Mu opioid receptor: a gateway to drug addiction. Curr. Opin. Neurobiol. 14 (2004) 370-378
15. Deneau G., Yanagita T., and Seevers M.H. Self-administration of psychoactive substances by the monkey. Psychopharmacologia 16 (1969) 30-48
16. Doherty M.C., Garfein R.S., Monterroso E., Brown D., and Vlahov D. Correlates of HIV infection among young adult short-term injection drug users. AIDS 14 (2000) 717-726
17. Eisenstein T.K., Rahim R.T., Feng P., Thingalaya N.K., and Meissler J.J. Effects of opioid tolerance and withdrawal on the immune system. J. Neuroimmun. Pharmacol. 1 (2006) 237-249
18. Fecho K., Dykstra L.A., and Lysle D.T. Evidence for beta adrenergic receptor involvement in the immunomodulatory effects of morphine. J. Pharmacol. Exp. Ther. 265 (1993) 1079-1087
19. Fecho K., Maslonek K.A., Dykstra L.A., and Lysle D.T. Alterations of immune status induced by the sympathetic nervous system: immunomodulatory effects of DMPP alone and in combination with morphine. Brain Behav. Immun. 7 (1993) 253-270
20. Fecho K., Maslonek K.A., Coussons-Read M.E., Dykstra L.A., and Lysle D.T. Macrophage-derived nitric oxide is involved in the depressed concanavalin A responsiveness of splenic lymphocytes from rats administered morphine in vivo. J. Immunol. 152 (1994) 5845-5852
21. Fecho K., Maslonek K.A., Dykstra L.A., and Lysle D.T. Mechanisms whereby macrophage-derived nitric oxide is involved in morphine-induced suppression of splenic lymphocyte proliferation. J. Pharmacol. Exp. Ther. 272 (1995) 477-483
22. Fecho K., Maslonek K.A., Dykstra L.A., and Lysle D.T. Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther. 277 (1996) 633-645
23. Freier D.O., and Fuchs B.A. A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity. J. Pharmacol. Exp. Ther. 270 (1994) 1127-1133
24. Friedman H., Newton C., and Klein T.W. Microbial infections, immunomodulation, and drugs of abuse. Clin. Microbiol. Rev. 16 (2003) 209-219
25. Gaveriaux-Ruff C., Matthes H.W., Peluso J., and Kieffer B.L. Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene. Proc. Natl. Acad. Sci. USA 95 (1998) 6326-6330
26. Goldberg S.R., Woods J.H., and Schuster C.R. Nalorphine-induced changes in morphine self-administration in rhesus monkeys. J. Pharmacol. Exp. Ther. 176 (1971) 464-471
27. Gomez-Flores R., and Weber R.J. Inhibition of interleukin-2 production and downregulation of IL-2 and transferrin receptors on rat splenic lymphocytes following PAG morphine administration: a role in natural killer and T cell suppression. J. Interferon Cytokine Res. 19 (1999) 625-630
28. Gomez-Flores R., and Weber R.J. In: Plotnikoff N.P., Faith R.E., Murgo A.J., and Good A.E. (Eds). Cytokines: Stress and Immunity (1999), CRC Press, Inc., Boca Raton 281-314
29. Gomez-Flores R., and Weber R.J. Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray. Immunopharmacology 48 (2000) 145-156
30. Gomez-Flores R., Suo J.L., and Weber R.J. Suppression of splenic macrophage functions following acute morphine action in the rat mesencephalon periaqueductal gray. Brain Behav. Immun. 13 (1999) 212-224
31. Govitrapong P., Suttitum T., Kotchabhakdi N., and Uneklabh T. Alterations of immune functions in heroin addicts and heroin withdrawal subjects. J. Pharmacol. Exp. Ther. 286 (1998) 883-889
32. Hall D.M., Suo J.L., and Weber R.J. Opioid mediated effects on the immune system: sympathetic nervous system involvement. J. Immunol. 83 (1998) 29-35
33. Hernandez M.C., Flores L.R., and Bayer B.M. Immunosuppression by morphine is mediated by central pathways. J. Pharmacol. Exp. Ther. 267 (1993) 1336-1341
34. Hunig T., Wallny H.J., Hartley J.K., Lawetzky A., and Tiefenthaler G. A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes. J. Exp. Med. 169 (1989) 73-86
35. Hussey H.H. Infections resulting from narcotic addiction. Report of 102 cases. Am. J. Med. 9 (1950) 186-193
36. Hyman S.E., Malenka R.C., and Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci. 29 (2006) 565-598
37. Jacobs E.H., Spijker S., Verhoog C.W., Kamprath K., de Vries T.J., Smit A.B., and Schoffelmeer A.N. Active heroin administration induces specific genomic responses in the nucleus accumbens shell. FASEB J. 16 (2002) 1961-1963
38. Jacobs E.H., Smit A.B., de Vries T.J., and Schoffelmeer A.N. Neuroadaptive effects of active versus passive drug administration in addiction research. Trends Pharmacol. Sci. 24 (2003) 566-573
39. Jacobs E.H., de Vries T.J., Smit A.B., and Schoffelmeer A.N. Gene transcripts selectively down-regulated in the shell of the nucleus accumbens long after heroin self-administration are up-regulated in the core independent of response contingency. FASEB J. 18 (2004) 200-202
40. Jones S., and Bonci A. Synaptic plasticity and drug addiction. Curr. Opin. Pharmacol. 5 (2005) 20-25
41. Kalivas P.W., and Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Am. J. Psychiatry 162 (2005) 1403-1413
42. Kee T.H. The habitual use of opium as a factor in the production of diseases. Philipp. J. Sci. 6 (1908) 63
43. Koob G.F., and Le Moal M. Review. Neurobiological mechanisms for opponent motivational processes in addiction. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 363 (2008) 3113-3123
44. Koob G.F., and Nestler E.J. The neurobiology of drug addiction. J. Neuropsychiatry Clin. Neurosci. 9 (1997) 482-497
45. Koob G.F., Pettit H.O., Ettenberg A., and Bloom F.E. Effects of opiate antagonists and their quaternary derivatives on heroin self-administration in the rat. J. Pharmacol. Exp. Ther. 229 (1984) 481-486
46. Kreek M.J. Immune function in heroin addicts and former heroin addicts in treatment: pre- and post-AIDS epidemic. NIDA Res. Monogr. 96 (1990) 192-219
47. Liang-Suo J., Gomez-Flores R., and Weber R.J. Immunosuppression induced by central action of morphine is not blocked by mifepristone (RU 486). Life Sci. 71 (2002) 2595-2602
48. Lockwood L.L., Silbert L.H., Fleshner M., Laudenslager M.L., Watkins L.R., and Maier S.F. Morphine-induced decreases in in vivo antibody responses. Brain Behav. Immun. 8 (1994) 24-36
49. Lockwood L.L., Silbert L.H., Fleshner M.R., McNeal C., Watkins L.R., Laudenslager M.L., Rice K.C., Weber R.J., and Maier S.F. Morphine-induced alterations in antibody levels: receptor and immune mechanisms. J. Pharmacol. Exp. Ther. 278 (1996) 689-696
50. Louria D.B., Hensle T., and Rose J. The major medical complications of heroin addiction. Ann. Intern. Med. 67 (1967) 1-22
51. Luttgens W.F. Endocarditis in main line opium addicts; report on 11 cases. Arch. Intern. Med. (Chic.) 83 (1949) 653-664
52. Lysle D.T., Hoffman K.E., and Dykstra L.A. Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status. J. Pharmacol. Exp. Ther. 277 (1996) 1533-1540
53. Markowitsch H.J. Which brain regions are critically involved in the retrieval of old episodic memory?. Brain Res. Brain Res. Rev. 21 (1995) 117-127
54. Martin T.J., Dworkin S.I., and Smith J.E. Alkylation of mu opioid receptors by beta-funaltrexamine in vivo: comparison of the effects on in situ binding and heroin self-administration in rats. J. Pharmacol. Exp. Ther. 272 (1995) 1135-1140
55. McAlonan G.M., Robbins T.W., and Everitt B.J. Effects of medial dorsal thalamic and ventral pallidal lesions on the acquisition of a conditioned place preference: further evidence for the involvement of the ventral striatopallidal system in reward-related processes. Neuroscience 52 (1993) 605-620
56. Mellon R.D., and Bayer B.M. Evidence for central opioid receptors in the immunomodulatory effects of morphine: review of potential mechanism(s) of action. J. Immunol. 83 (1998) 19-28
57. Mellon R.D., and Bayer B.M. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity. Brain Res. 789 (1998) 56-67
58. Nelson C.J., Dykstra L.A., and Lysle D.T. Comparison of the time course of morphine's analgesic and immunologic effects. Anesth. Analg. 85 (1997) 620-626
59. Nelson C.J., Schneider G.M., and Lysle D.T. Involvement of central mu- but not delta- or kappa-opioid receptors in immunomodulation. Brain Behav. Immun. 14 (2000) 170-184
60. Novick D.M., Ochshorn M., Ghali V., Croxson T.S., Mercer W.D., Chiorazzi N., and Kreek M.J. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. J. Pharmacol. Exp. Ther. 250 (1989) 606-610
61. Perneger T.V., Giner F., del R.M., and Mino A. Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. BMJ 317 (1998) 13-18
62. Pert C.B., Ruff M.R., Weber R.J., and Herkenham M. Neuropeptides and their receptors: a psychosomatic network. J. Immunol. 135 (1985) 820s-826s
63. Piazza P.V., and Le Moal M. The role of stress in drug self-administration. Trends Pharmacol. Sci. 19 (1998) 67-74
64. Rahim R.T., Meissler Jr. J.J., Adler M.W., and Eisenstein T.K. Splenic macrophages and B cells mediate immunosuppression following abrupt withdrawal from morphine. J. Leukoc. Biol. 78 (2005) 1185-1191
65. Rojavin M., Szabo I., Bussiere J.L., Rogers T.J., Adler M.W., and Eisenstein T.K. Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages. Life Sci. 53 (1993) 997-1006
66. Sacerdote P., Franchi S., Gerra G., Leccese V., Panerai A.E., and Somaini L. Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function. Brain Behav. Immun. 22 (2008) 606-613
67. Sapira J.D. The narcotic addict as a medical patient. Am. J. Med. 45 (1968) 555-588
68. Schneider G.M., and Lysle D.T. Role of central mu-opioid receptors in the modulation of nitric oxide production by splenocytes. J. Immunol. 89 (1998) 150-159
69. Schuster C.R., and Thompson T. Self administration of and behavioral dependence on drugs. Annu. Rev. Pharmacol. 9 (1969) 483-502
70. Sei Y., Yoshimoto K., McIntyre T., Skolnick P., and Arora P.K. Morphine-induced thymic hypoplasia is glucocorticoid-dependent. J. Immunol. 146 (1991) 194-198
71. Self D.W. Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system. Neuropharmacology 47 Suppl. 1 (2004) 242-255
72. Shavit Y., Lewis J.W., Terman G.W., Gale R.P., and Liebeskind J.C. Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science 223 (1984) 188-190
73. Shavit Y., Depaulis A., Martin F.C., Terman G.W., Pechnick R.N., Zane C.J., Gale R.P., and Liebeskind J.C. Involvement of brain opiate receptors in the immune-suppressive effect of morphine. Proc. Natl. Acad. Sci. USA 83 (1986) 7114-7117
74. Sibinga N.E., and Goldstein A. Opioid peptides and opioid receptors in cells of the immune system. Annu. Rev. Immunol. 6 (1988) 219-249
75. 35S]thio]-triphosphate binding. Proc. Natl. Acad. Sci. USA 92 (1995) 7242-7246
76. Sim-Selley L.J., Selley D.E., Vogt L.J., Childers S.R., and Martin T.J. Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain. J. Neurosci. 20 (2000) 4555-4562
77. Smith J.E., Co C., Freeman M.E., Sands M.P., and Lane J.D. Neurotransmitter turnover in rat striatum is correlated with morphine self-administration. Nature 287 (1980) 152-154
78. Smith J.E., Co C., Freeman M.E., and Lane J.D. Brain neurotransmitter turnover correlated with morphine-seeking behavior of rats. Pharmacol. Biochem. Behav. 16 (1982) 509-519
79. Smith J.E., Koves T.R., and Co C. Brain neurotransmitter turnover rates during rat intravenous cocaine self-administration. Neuroscience 117 (2003) 461-475
80. Tennant F. Hepatitis C, B, D, and A: contrasting features and liver function abnormalities in heroin addicts. J. Addict. Dis. 20 (2001) 9-17
81. Tubaro E., Borelli G., Croce C., Cavallo G., and Santiangeli C. Effect of morphine on resistance to infection. J. Infect. Dis. 148 (1983) 656-666
82. Tubaro E., Avico U., Santiangeli C., Zuccaro P., Cavallo G., Pacifici R., Croce C., and Borelli G. Morphine and methadone impact on human phagocytic physiology. Int. J. Immunopharmacol. 7 (1985) 865-874
83. Vaccarino F.J., Bloom F.E., and Koob G.F. Blockade of nucleus accumbens opiate receptors attenuates intravenous heroin reward in the rat. Psychopharmacology (Berlin) 86 (1985) 37-42
84. Vaccarino F.J., Pettit H.O., Bloom F.E., and Koob G.F. Effects of intracerebroventricular administration of methyl naloxonium chloride on heroin self-administration in the rat. Pharmacol. Biochem. Behav. 23 (1985) 495-498
85. Volkow N.D., Fowler J.S., and Wang G.J. Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Behav. Pharmacol. 13 (2002) 355-366
86. Wang J., Charboneau R., Balasubramanian S., Barke R.A., Loh H.H., and Roy S. The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the mu-opioid receptor. J. Leukoc. Biol. 71 (2002) 782-790
87. Weber R.J., and Pert C.B. In: Muller E.E., and Genazzani A.R. (Eds). Central and Peripheral Endorphins: Basic and Clinical Aspects (1984), Raven Press, New York 35-42
88. Weber R.J., and Pert A. The periaqueductal gray matter mediates opiate-induced immunosuppression. Science 245 (1989) 188-190
89. Weber R.J., and Pert A. In: Smith B., and Adelman G. (Eds). Encyclopedia of Neuroscience (1999), Birkhauser, Boston
90. Weber R.J., Ikejiri B., Rice K.C., Pert A., and Hagan A.A. Opiate receptor mediated regulation of the immune response in vivo. NIDA Res. Monogr. 48 (1987) 341-348
91. Weber R.J., Band L.C., deCosta B., Pert A., and Rice K.C. Neural control of immune function: opioids, opioid receptors and immunosuppression. NIDA Res. Monogr. 105 (1991) 96-102
92. Weber R.J., Gomez-Flores R., Sora I., and Uhl G.R. Loss of morphine-induced suppression of NK cell activity and T-cell functions in μ-opioid receptor knockout mice. Am. J. Immunol. 2 (2006) 35-39
93. Weeks J.R., and Collins R.J. Changes in morphine self-administration in rats induced by prostaglandin E1 and naloxone. Prostaglandins 12 (1976) 11-19
94. Wise R.A., and Bozarth M.A. Brain mechanisms of drug reward and euphoria. Psychiatr. Med. 3 (1985) 445-460